|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:EIF6-BANF2 (FusionGDB2 ID:26093) |
Fusion Gene Summary for EIF6-BANF2 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: EIF6-BANF2 | Fusion gene ID: 26093 | Hgene | Tgene | Gene symbol | EIF6 | BANF2 | Gene ID | 3692 | 140836 |
| Gene name | eukaryotic translation initiation factor 6 | BANF family member 2 | |
| Synonyms | CAB|EIF3A|ITGB4BP|b(2)gcn|eIF-6|p27(BBP)|p27BBP | BAF-L|BAF2|BAFL|C20orf179 | |
| Cytomap | 20q11.22 | 20p12.1 | |
| Type of gene | protein-coding | protein-coding | |
| Description | eukaryotic translation initiation factor 6B4 integrin interactoreukaryotic translation initiation factor 3Ap27 beta-4 integrin-binding protein | barrier-to-autointegration factor-like proteinbarrier to autointegration factor 2testis secretory sperm-binding protein Li 212a | |
| Modification date | 20200313 | 20200313 | |
| UniProtAcc | P56537 | . | |
| Ensembl transtripts involved in fusion gene | ENST00000374436, ENST00000374443, ENST00000374450, ENST00000462894, | ENST00000545418, ENST00000377805, ENST00000246090, ENST00000467330, | |
| Fusion gene scores | * DoF score | 2 X 3 X 2=12 | 2 X 2 X 2=8 |
| # samples | 3 | 3 | |
| ** MAII score | log2(3/12*10)=1.32192809488736 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(3/8*10)=1.90689059560852 | |
| Context | PubMed: EIF6 [Title/Abstract] AND BANF2 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | EIF6(33867369)-BANF2(17716310), # samples:2 | ||
| Anticipated loss of major functional domain due to fusion event. | EIF6-BANF2 seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF. | ||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Fusion gene breakpoints across EIF6 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene breakpoints across BANF2 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | BLCA | TCGA-XF-A8HG-01A | EIF6 | chr20 | 33867369 | - | BANF2 | chr20 | 17716310 | + |
| ChimerDB4 | BLCA | TCGA-XF-A8HG-01A | EIF6 | chr20 | 33867369 | - | BANF2 | chr20 | 17716310 | + |
Top |
Fusion Gene ORF analysis for EIF6-BANF2 |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| In-frame | ENST00000374436 | ENST00000545418 | EIF6 | chr20 | 33867369 | - | BANF2 | chr20 | 17716310 | + |
| Frame-shift | ENST00000374436 | ENST00000377805 | EIF6 | chr20 | 33867369 | - | BANF2 | chr20 | 17716310 | + |
| Frame-shift | ENST00000374436 | ENST00000246090 | EIF6 | chr20 | 33867369 | - | BANF2 | chr20 | 17716310 | + |
| 5CDS-3UTR | ENST00000374436 | ENST00000467330 | EIF6 | chr20 | 33867369 | - | BANF2 | chr20 | 17716310 | + |
| Frame-shift | ENST00000374443 | ENST00000545418 | EIF6 | chr20 | 33867369 | - | BANF2 | chr20 | 17716310 | + |
| In-frame | ENST00000374443 | ENST00000377805 | EIF6 | chr20 | 33867369 | - | BANF2 | chr20 | 17716310 | + |
| In-frame | ENST00000374443 | ENST00000246090 | EIF6 | chr20 | 33867369 | - | BANF2 | chr20 | 17716310 | + |
| 5CDS-3UTR | ENST00000374443 | ENST00000467330 | EIF6 | chr20 | 33867369 | - | BANF2 | chr20 | 17716310 | + |
| Frame-shift | ENST00000374450 | ENST00000545418 | EIF6 | chr20 | 33867369 | - | BANF2 | chr20 | 17716310 | + |
| In-frame | ENST00000374450 | ENST00000377805 | EIF6 | chr20 | 33867369 | - | BANF2 | chr20 | 17716310 | + |
| In-frame | ENST00000374450 | ENST00000246090 | EIF6 | chr20 | 33867369 | - | BANF2 | chr20 | 17716310 | + |
| 5CDS-3UTR | ENST00000374450 | ENST00000467330 | EIF6 | chr20 | 33867369 | - | BANF2 | chr20 | 17716310 | + |
| intron-3CDS | ENST00000462894 | ENST00000545418 | EIF6 | chr20 | 33867369 | - | BANF2 | chr20 | 17716310 | + |
| intron-3CDS | ENST00000462894 | ENST00000377805 | EIF6 | chr20 | 33867369 | - | BANF2 | chr20 | 17716310 | + |
| intron-3CDS | ENST00000462894 | ENST00000246090 | EIF6 | chr20 | 33867369 | - | BANF2 | chr20 | 17716310 | + |
| intron-3UTR | ENST00000462894 | ENST00000467330 | EIF6 | chr20 | 33867369 | - | BANF2 | chr20 | 17716310 | + |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000374436 | EIF6 | chr20 | 33867369 | - | ENST00000545418 | BANF2 | chr20 | 17716310 | + | 1152 | 956 | 228 | 986 | 252 |
| ENST00000374443 | EIF6 | chr20 | 33867369 | - | ENST00000377805 | BANF2 | chr20 | 17716310 | + | 928 | 721 | 50 | 751 | 233 |
| ENST00000374443 | EIF6 | chr20 | 33867369 | - | ENST00000246090 | BANF2 | chr20 | 17716310 | + | 928 | 721 | 50 | 751 | 233 |
| ENST00000374450 | EIF6 | chr20 | 33867369 | - | ENST00000377805 | BANF2 | chr20 | 17716310 | + | 1200 | 993 | 265 | 1023 | 252 |
| ENST00000374450 | EIF6 | chr20 | 33867369 | - | ENST00000246090 | BANF2 | chr20 | 17716310 | + | 1200 | 993 | 265 | 1023 | 252 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000374436 | ENST00000545418 | EIF6 | chr20 | 33867369 | - | BANF2 | chr20 | 17716310 | + | 0.004925011 | 0.99507505 |
| ENST00000374443 | ENST00000377805 | EIF6 | chr20 | 33867369 | - | BANF2 | chr20 | 17716310 | + | 0.02703466 | 0.9729653 |
| ENST00000374443 | ENST00000246090 | EIF6 | chr20 | 33867369 | - | BANF2 | chr20 | 17716310 | + | 0.02703466 | 0.9729653 |
| ENST00000374450 | ENST00000377805 | EIF6 | chr20 | 33867369 | - | BANF2 | chr20 | 17716310 | + | 0.008746397 | 0.9912537 |
| ENST00000374450 | ENST00000246090 | EIF6 | chr20 | 33867369 | - | BANF2 | chr20 | 17716310 | + | 0.008746397 | 0.9912537 |
Top |
Fusion Genomic Features for EIF6-BANF2 |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| EIF6 | chr20 | 33867368 | - | BANF2 | chr20 | 17716309 | + | 0.000555444 | 0.99944454 |
| EIF6 | chr20 | 33867368 | - | BANF2 | chr20 | 17716309 | + | 0.000555444 | 0.99944454 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for EIF6-BANF2 |
| Go to FGviewer for the breakpoints of chr20:33867369-chr20:17716310 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| EIF6 | . |
| FUNCTION: Binds to the 60S ribosomal subunit and prevents its association with the 40S ribosomal subunit to form the 80S initiation complex in the cytoplasm. Behaves as a stimulatory translation initiation factor downstream insulin/growth factors. Is also involved in ribosome biogenesis. Associates with pre-60S subunits in the nucleus and is involved in its nuclear export. Cytoplasmic release of TIF6 from 60S subunits and nuclear relocalization is promoted by a RACK1 (RACK1)-dependent protein kinase C activity (PubMed:10085284, PubMed:14654845, PubMed:21536732). In tissues responsive to insulin, controls fatty acid synthesis and glycolysis by exerting translational control of adipogenic transcription factors such as CEBPB, CEBPD and ATF4 that have G/C rich or uORF in their 5'UTR. Required for ROS-dependent megakaryocyte maturation and platelets formation, controls the expression of mitochondrial respiratory chain genes involved in reactive oxygen species (ROS) synthesis (By similarity). Involved in miRNA-mediated gene silencing by the RNA-induced silencing complex (RISC). Required for both miRNA-mediated translational repression and miRNA-mediated cleavage of complementary mRNAs by RISC (PubMed:17507929). Modulates cell cycle progression and global translation of pre-B cells, its activation seems to be rate-limiting in tumorigenesis and tumor growth (By similarity). {ECO:0000255|HAMAP-Rule:MF_03132, ECO:0000269|PubMed:10085284, ECO:0000269|PubMed:14654845, ECO:0000269|PubMed:17507929, ECO:0000269|PubMed:21536732}. | FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for EIF6-BANF2 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >In-frame_ENST00000374436_ENST00000545418_TCGA-XF-A8HG-01A_EIF6_chr20_33867369_-_BANF2_chr20_17716310_length(transcript)=1152nt_BP=956nt GTGAGGGGAACCTGGGAGGGTCAGCTCCGGTCCTGGGTCGGGAGGGGTGGGGGCCAGAGGATTCAGGGCCGGAGGTTCTGGTGGGGGCCC AGTGGGCGGGACCCGAGGACGGAGGGGCCGGGAGGCCGAGAGGGGCGGGGTCGCGGCGGGGCCTGAGGGACGGAGGCCGGGATACTTGGG AAAGGATCCGCCGGCCTTGAACTCCCGCCTCCGCCGCCCCTAGGCCTCATGGCGGTCCGAGCTTCGTTCGAGAACAACTGTGAGATCGGC TGCTTTGCCAAGCTCACCAACACCTACTGTCTGGTAGCGATCGGAGGCTCAGAGAACTTCTACAGTGTGTTCGAGGGCGAGCTCTCCGAT ACCATCCCCGTGGTGCACGCGTCTATCGCCGGCTGCCGCATCATCGGGCGCATGTGTGTGGGGAACAGGCACGGTCTCCTGGTACCCAAC AATACCACCGACCAGGAGCTGCAACACATTCGCAACAGCCTCCCAGACACAGTGCAGATTAGGCGGGTGGAGGAGCGGCTCTCAGCCTTG GGCAATGTCACCACCTGCAATGACTACGTGGCCTTGGTCCACCCAGACTTGGACAGGGAGACAGAAGAAATTCTGGCAGATGTGCTCAAG GTGGAAGTCTTCAGACAGACAGTGGCCGACCAGGTGCTAGTAGGAAGCTACTGTGTCTTCAGCAATCAGGGAGGGCTGGTGCATCCCAAG ACTTCAATTGAAGACCAGGATGAGCTGTCCTCTCTTCTTCAAGTCCCCCTTGTGGCGGGGACTGTGAACCGAGGCAGTGAGGTGATTGCT GCTGGGATGGTGGTGAATGACTGGTGTGCCTTCTGTGGCCTGGACACAACCAGCACAGAGCTGTCAGTGGTGGAGAGTGTCTTCAAGCTG AATGAAGCCCAGCCTAGCACCATTGCCACCAGCATGCGGGATTCCCTCATTGACAGGCCTACATCCTGCTGGGACAATTCCTTCTGATGC ACAAGAATGAAGCCGAGTTTCAGAGGTGGCTCATTTGCTGTTTTGGTGCCACTGAGTGTGAGGCCCAGCAGACTTCTCACTGCCTCAAGG >In-frame_ENST00000374436_ENST00000545418_TCGA-XF-A8HG-01A_EIF6_chr20_33867369_-_BANF2_chr20_17716310_length(amino acids)=252AA_start in transcript=228_stop in transcript=986 MAVRASFENNCEIGCFAKLTNTYCLVAIGGSENFYSVFEGELSDTIPVVHASIAGCRIIGRMCVGNRHGLLVPNNTTDQELQHIRNSLPD TVQIRRVEERLSALGNVTTCNDYVALVHPDLDRETEEILADVLKVEVFRQTVADQVLVGSYCVFSNQGGLVHPKTSIEDQDELSSLLQVP -------------------------------------------------------------- >In-frame_ENST00000374443_ENST00000377805_TCGA-XF-A8HG-01A_EIF6_chr20_33867369_-_BANF2_chr20_17716310_length(transcript)=928nt_BP=721nt TCCAAGGTACAGTCGCCGCGTGCGGAGCTTGTTACTGGTTACTTGGCCTCATGGCGGTCCGAGCTTCGTTCGAGAACAACTGTGAGATCG GCTGCTTTGCCAAGCTCACCAACACCTACTGTCTGGTAGCGATCGGAGGCTCAGAGAACTTCTACAGGTGCGGCGGGAGCCCCGGGGCTT ACGGTGGCGGGGAGGCGTGCGCAGGAGTCAAGAGCTCCGGCAGTGGGAGGGTGCCGGCCCCTCTGCCCCGCCACCACCGAGTCCATGTCC CTACAGTGTGTTCGAGGGCGAGCTCTCCGATACCATCCCCGTGGTGCACGCGTCTATCGCCGGCTGCCGCATCATCGGGCGCATGTGTGT GGGAGACAGAAGAAATTCTGGCAGATGTGCTCAAGGTGGAAGTCTTCAGACAGACAGTGGCCGACCAGGTGCTAGTAGGAAGCTACTGTG TCTTCAGCAATCAGGGAGGGCTGGTGCATCCCAAGACTTCAATTGAAGACCAGGATGAGCTGTCCTCTCTTCTTCAAGTCCCCCTTGTGG CGGGGACTGTGAACCGAGGCAGTGAGGTGATTGCTGCTGGGATGGTGGTGAATGACTGGTGTGCCTTCTGTGGCCTGGACACAACCAGCA CAGAGCTGTCAGTGGTGGAGAGTGTCTTCAAGCTGAATGAAGCCCAGCCTAGCACCATTGCCACCAGCATGCGGGATTCCCTCATTGACA GGCCTACATCCTGCTGGGACAATTCCTTCTGATGCACAAGAATGAAGCCGAGTTTCAGAGGTGGCTCATTTGCTGTTTTGGTGCCACTGA GTGTGAGGCCCAGCAGACTTCTCACTGCCTCAAGGAGTGGTGTGCCTGCTTCCTGTAGACACAAACCTCATTGCTGCCCCCCACCACCCT >In-frame_ENST00000374443_ENST00000377805_TCGA-XF-A8HG-01A_EIF6_chr20_33867369_-_BANF2_chr20_17716310_length(amino acids)=233AA_start in transcript=50_stop in transcript=751 MAVRASFENNCEIGCFAKLTNTYCLVAIGGSENFYRCGGSPGAYGGGEACAGVKSSGSGRVPAPLPRHHRVHVPTVCSRASSPIPSPWCT RLSPAAASSGACVWETEEILADVLKVEVFRQTVADQVLVGSYCVFSNQGGLVHPKTSIEDQDELSSLLQVPLVAGTVNRGSEVIAAGMVV -------------------------------------------------------------- >In-frame_ENST00000374443_ENST00000246090_TCGA-XF-A8HG-01A_EIF6_chr20_33867369_-_BANF2_chr20_17716310_length(transcript)=928nt_BP=721nt TCCAAGGTACAGTCGCCGCGTGCGGAGCTTGTTACTGGTTACTTGGCCTCATGGCGGTCCGAGCTTCGTTCGAGAACAACTGTGAGATCG GCTGCTTTGCCAAGCTCACCAACACCTACTGTCTGGTAGCGATCGGAGGCTCAGAGAACTTCTACAGGTGCGGCGGGAGCCCCGGGGCTT ACGGTGGCGGGGAGGCGTGCGCAGGAGTCAAGAGCTCCGGCAGTGGGAGGGTGCCGGCCCCTCTGCCCCGCCACCACCGAGTCCATGTCC CTACAGTGTGTTCGAGGGCGAGCTCTCCGATACCATCCCCGTGGTGCACGCGTCTATCGCCGGCTGCCGCATCATCGGGCGCATGTGTGT GGGAGACAGAAGAAATTCTGGCAGATGTGCTCAAGGTGGAAGTCTTCAGACAGACAGTGGCCGACCAGGTGCTAGTAGGAAGCTACTGTG TCTTCAGCAATCAGGGAGGGCTGGTGCATCCCAAGACTTCAATTGAAGACCAGGATGAGCTGTCCTCTCTTCTTCAAGTCCCCCTTGTGG CGGGGACTGTGAACCGAGGCAGTGAGGTGATTGCTGCTGGGATGGTGGTGAATGACTGGTGTGCCTTCTGTGGCCTGGACACAACCAGCA CAGAGCTGTCAGTGGTGGAGAGTGTCTTCAAGCTGAATGAAGCCCAGCCTAGCACCATTGCCACCAGCATGCGGGATTCCCTCATTGACA GGCCTACATCCTGCTGGGACAATTCCTTCTGATGCACAAGAATGAAGCCGAGTTTCAGAGGTGGCTCATTTGCTGTTTTGGTGCCACTGA GTGTGAGGCCCAGCAGACTTCTCACTGCCTCAAGGAGTGGTGTGCCTGCTTCCTGTAGACACAAACCTCATTGCTGCCCCCCACCACCCT >In-frame_ENST00000374443_ENST00000246090_TCGA-XF-A8HG-01A_EIF6_chr20_33867369_-_BANF2_chr20_17716310_length(amino acids)=233AA_start in transcript=50_stop in transcript=751 MAVRASFENNCEIGCFAKLTNTYCLVAIGGSENFYRCGGSPGAYGGGEACAGVKSSGSGRVPAPLPRHHRVHVPTVCSRASSPIPSPWCT RLSPAAASSGACVWETEEILADVLKVEVFRQTVADQVLVGSYCVFSNQGGLVHPKTSIEDQDELSSLLQVPLVAGTVNRGSEVIAAGMVV -------------------------------------------------------------- >In-frame_ENST00000374450_ENST00000377805_TCGA-XF-A8HG-01A_EIF6_chr20_33867369_-_BANF2_chr20_17716310_length(transcript)=1200nt_BP=993nt GTCGATGACAGCTCCTAAAAAGCTCCTGAATGAATAATGAATGAATGAACGCGAGCAGGCTAGGCGTGGGGCCAGGCGGGGTCGCGCCCA GACCGCTCGCGACCATAGAGTCCGCCGGAGGCCGGAGGTAGAGGGGCTGGATGCGTGGCGGGGAGCGCCGGGCTCTCCCGGAAGTCTCCC TGGACGGAAGTGGAAACGGAAACCTTTTTAGGGAGTCCAAGGTACAGTCGCCGCGTGCGGAGCTTGTTACTGGTTACTTGGCCTCATGGC GGTCCGAGCTTCGTTCGAGAACAACTGTGAGATCGGCTGCTTTGCCAAGCTCACCAACACCTACTGTCTGGTAGCGATCGGAGGCTCAGA GAACTTCTACAGTGTGTTCGAGGGCGAGCTCTCCGATACCATCCCCGTGGTGCACGCGTCTATCGCCGGCTGCCGCATCATCGGGCGCAT GTGTGTGGGGAACAGGCACGGTCTCCTGGTACCCAACAATACCACCGACCAGGAGCTGCAACACATTCGCAACAGCCTCCCAGACACAGT GCAGATTAGGCGGGTGGAGGAGCGGCTCTCAGCCTTGGGCAATGTCACCACCTGCAATGACTACGTGGCCTTGGTCCACCCAGACTTGGA CAGGGAGACAGAAGAAATTCTGGCAGATGTGCTCAAGGTGGAAGTCTTCAGACAGACAGTGGCCGACCAGGTGCTAGTAGGAAGCTACTG TGTCTTCAGCAATCAGGGAGGGCTGGTGCATCCCAAGACTTCAATTGAAGACCAGGATGAGCTGTCCTCTCTTCTTCAAGTCCCCCTTGT GGCGGGGACTGTGAACCGAGGCAGTGAGGTGATTGCTGCTGGGATGGTGGTGAATGACTGGTGTGCCTTCTGTGGCCTGGACACAACCAG CACAGAGCTGTCAGTGGTGGAGAGTGTCTTCAAGCTGAATGAAGCCCAGCCTAGCACCATTGCCACCAGCATGCGGGATTCCCTCATTGA CAGGCCTACATCCTGCTGGGACAATTCCTTCTGATGCACAAGAATGAAGCCGAGTTTCAGAGGTGGCTCATTTGCTGTTTTGGTGCCACT GAGTGTGAGGCCCAGCAGACTTCTCACTGCCTCAAGGAGTGGTGTGCCTGCTTCCTGTAGACACAAACCTCATTGCTGCCCCCCACCACC >In-frame_ENST00000374450_ENST00000377805_TCGA-XF-A8HG-01A_EIF6_chr20_33867369_-_BANF2_chr20_17716310_length(amino acids)=252AA_start in transcript=265_stop in transcript=1023 MAVRASFENNCEIGCFAKLTNTYCLVAIGGSENFYSVFEGELSDTIPVVHASIAGCRIIGRMCVGNRHGLLVPNNTTDQELQHIRNSLPD TVQIRRVEERLSALGNVTTCNDYVALVHPDLDRETEEILADVLKVEVFRQTVADQVLVGSYCVFSNQGGLVHPKTSIEDQDELSSLLQVP -------------------------------------------------------------- >In-frame_ENST00000374450_ENST00000246090_TCGA-XF-A8HG-01A_EIF6_chr20_33867369_-_BANF2_chr20_17716310_length(transcript)=1200nt_BP=993nt GTCGATGACAGCTCCTAAAAAGCTCCTGAATGAATAATGAATGAATGAACGCGAGCAGGCTAGGCGTGGGGCCAGGCGGGGTCGCGCCCA GACCGCTCGCGACCATAGAGTCCGCCGGAGGCCGGAGGTAGAGGGGCTGGATGCGTGGCGGGGAGCGCCGGGCTCTCCCGGAAGTCTCCC TGGACGGAAGTGGAAACGGAAACCTTTTTAGGGAGTCCAAGGTACAGTCGCCGCGTGCGGAGCTTGTTACTGGTTACTTGGCCTCATGGC GGTCCGAGCTTCGTTCGAGAACAACTGTGAGATCGGCTGCTTTGCCAAGCTCACCAACACCTACTGTCTGGTAGCGATCGGAGGCTCAGA GAACTTCTACAGTGTGTTCGAGGGCGAGCTCTCCGATACCATCCCCGTGGTGCACGCGTCTATCGCCGGCTGCCGCATCATCGGGCGCAT GTGTGTGGGGAACAGGCACGGTCTCCTGGTACCCAACAATACCACCGACCAGGAGCTGCAACACATTCGCAACAGCCTCCCAGACACAGT GCAGATTAGGCGGGTGGAGGAGCGGCTCTCAGCCTTGGGCAATGTCACCACCTGCAATGACTACGTGGCCTTGGTCCACCCAGACTTGGA CAGGGAGACAGAAGAAATTCTGGCAGATGTGCTCAAGGTGGAAGTCTTCAGACAGACAGTGGCCGACCAGGTGCTAGTAGGAAGCTACTG TGTCTTCAGCAATCAGGGAGGGCTGGTGCATCCCAAGACTTCAATTGAAGACCAGGATGAGCTGTCCTCTCTTCTTCAAGTCCCCCTTGT GGCGGGGACTGTGAACCGAGGCAGTGAGGTGATTGCTGCTGGGATGGTGGTGAATGACTGGTGTGCCTTCTGTGGCCTGGACACAACCAG CACAGAGCTGTCAGTGGTGGAGAGTGTCTTCAAGCTGAATGAAGCCCAGCCTAGCACCATTGCCACCAGCATGCGGGATTCCCTCATTGA CAGGCCTACATCCTGCTGGGACAATTCCTTCTGATGCACAAGAATGAAGCCGAGTTTCAGAGGTGGCTCATTTGCTGTTTTGGTGCCACT GAGTGTGAGGCCCAGCAGACTTCTCACTGCCTCAAGGAGTGGTGTGCCTGCTTCCTGTAGACACAAACCTCATTGCTGCCCCCCACCACC >In-frame_ENST00000374450_ENST00000246090_TCGA-XF-A8HG-01A_EIF6_chr20_33867369_-_BANF2_chr20_17716310_length(amino acids)=252AA_start in transcript=265_stop in transcript=1023 MAVRASFENNCEIGCFAKLTNTYCLVAIGGSENFYSVFEGELSDTIPVVHASIAGCRIIGRMCVGNRHGLLVPNNTTDQELQHIRNSLPD TVQIRRVEERLSALGNVTTCNDYVALVHPDLDRETEEILADVLKVEVFRQTVADQVLVGSYCVFSNQGGLVHPKTSIEDQDELSSLLQVP -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for EIF6-BANF2 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for EIF6-BANF2 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
| Hgene | EIF6 | P56537 | DB09130 | Copper | Small molecule | Approved|Investigational | |
| Hgene | EIF6 | P56537 | DB09130 | Copper | Small molecule | Approved|Investigational | |
| Hgene | EIF6 | P56537 | DB09130 | Copper | Small molecule | Approved|Investigational | |
| Hgene | EIF6 | P56537 | DB09130 | Copper | Small molecule | Approved|Investigational |
Top |
Related Diseases for EIF6-BANF2 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | EIF6 | C0006142 | Malignant neoplasm of breast | 1 | CTD_human |
| Hgene | EIF6 | C0019693 | HIV Infections | 1 | CTD_human |
| Hgene | EIF6 | C0678222 | Breast Carcinoma | 1 | CTD_human |
| Hgene | EIF6 | C1257931 | Mammary Neoplasms, Human | 1 | CTD_human |
| Hgene | EIF6 | C1458155 | Mammary Neoplasms | 1 | CTD_human |
| Hgene | EIF6 | C4505456 | HIV Coinfection | 1 | CTD_human |
| Hgene | EIF6 | C4704874 | Mammary Carcinoma, Human | 1 | CTD_human |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies